RxDoctor Payments Data

Kendral Knight, MD

Nephrology · Norman, OKNPI 1275783250

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for nephrology clinicians in OK, where the typical reported total is $2,111.

$2,111in general payments, 2019–2025

Across 86 payments — averaging $24.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Travere Therapeutics, Inc.$440
  • AstraZeneca$436
  • Otsuka America Pharmaceutical, Inc.$186
  • OPKO Pharmaceuticals, LLC$134
  • Mallinckrodt Enterprises LLC$124
  • Amgen$117
  • plus $675 from 17 others

What the payments were for

  • Food & beverage$2,06998%
  • Education$422%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,111 in reported general payments places this provider in the 50th percentile of 106 nephrology providers in Oklahoma.

See all nephrology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$133,241
Medicare patients
419
Services billed
1,182

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProsolParenteral Amino Acid 20% No.149$9,015
Calcium Acetate13$1,548
Nifedipine ErNifedipine46$1,009
Losartan Potassium64$727
Torsemide33$718
Amlodipine Besylate60$498
Metolazone15$464
Carvedilol33$448
Isosorbide Mononitrate ErIsosorbide Mononitrate29$390
Potassium Chloride20$328
Calcitriol15$255
Hydralazine Hcl30$255
Lisinopril34$221
Furosemide14$187

Paid to pharmacies, not to this prescriber.

Other nephrology in Norman

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →